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Pseudocontact shifta b s t r a c t
The C-terminal b-hairpin of NS2B (NS2Bc) in the dengue virus NS2B–NS3 protease is required for full
enzymatic activity. In crystal structures without inhibitor and in the complex with bovine pancre-
atic trypsin inhibitor (BPTI), NS2Bc is displaced from the active site. In contrast, nuclear magnetic
resonance (NMR) studies in solution only ever showed NS2Bc in the enzymatically active closed con-
formation. Here we demonstrate by pseudocontact shifts from a lanthanide tag that NS2Bc remains
in the closed conformation also in the complex with BPTI. Therefore, the closed conformation is the
best template for drug discovery.
Structured summary of protein interactions:
NS2B, BPTI and NS3 physically interact by nuclear magnetic resonance (View interaction)
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction the protease assumes a closed conformation in solution, whereDengue virus (DENV) is the most important mosquito-borne
pathogen in terms of human suffering and cost, with a high rate
of hospitalization and potentially deadly outcome [1]. There are
four different closely related serotypes (DENV-1–DENV-4). To date,
no approved vaccine or drug is available for any of them, but an
established drug target is presented by the NS2B–NS3 protease
(NS2B–NS3pro) formed from segments of the non-structural virus
proteins NS2B and NS3 [2,3]. For a long time, however, develop-
ment of an inhibitor of NS2B–NS3pro has been hampered by difﬁ-
culties to ascertain the correct structure of the protein.
The ﬁrst crystal structure of NS2B–NS3pro, determined for a
construct from DENV-2, displayed an open conformation in which
the C-terminal segment of NS2B (NS2Bc; residues 66⁄–95⁄;
throughout this text, residue numbers of NS2B are identiﬁed by
asterisks) was located far from the active site in an inactive confor-
mation (Fig. 1) [4]. Subsequent NMR studies showed, however, thatNS2Bc lines the substrate binding site [5–7], in complete analogy
to the structure of the related West Nile virus protease [4,8,9]. A
crystal structure of NS2B–NS3pro from DENV-3 in complex with
a peptide inhibitor conﬁrmed the closed conformation [10], but
the same protein in complex with the high-afﬁnity (Ki = 26 nM
[11]) trypsin inhibitor bovine pancreatic trypsin inhibitor (BPTI)
lacked any electron density for NS2Bc, indicating once again an
open conformation [10].
In the absence of ﬁrm information about the correct target struc-
ture in solution, computational ligand binding studies targeting the
active site used either closed or open conformations of the NS2B–
NS3 protease [12–28]. Unfortunately, the actual three-dimensional
(3D) structure in solution cannot readily be determined by conven-
tional NMR methods due to poor spectral resolution, line broaden-
ing by conformational exchange and limited protein stability. In the
case of the NS2B–NS3pro complex with BPTI, its high molecular
weight (35 kDa) further impedes NMR analysis.
Here we show that, in solution, the closed conformation pre-
vails also in the presence of BPTI. This result was obtained by mea-
suring pseudocontact shifts (PCS) of 15N-HSQC cross-peaks of
backbone amides in uniformly and selectively 15N-labelled sam-
ples with a paramagnetic lanthanide tag attached to NS3pro. The
PCSs provide a clear picture of the binding mode of BPTI at the
active site and of the location of the b-hairpin of NS2Bc.
Fig. 1. Ribbon drawings of the dengue virus NS2B–NS3 protease as observed in crystal structures. NS3pro is shown in grey and NS2B in orange. The active site is located near
the centre top in the orientation shown. The N-terminal segment of NS2B (NS2Bn, residues 49⁄–65⁄) includes a structurally conserved b-strand that inserts into the N-
terminal b-barrel of NS3pro. The C-terminal segment of NS2B (NS2Bc, residues 66⁄–95⁄) differs greatly between the open (panel A, PDB ID: 2FOM) and closed (panel B, PDB ID:
3U1I [10]) conformations detected by X-ray crystallography [4,10]. The arrow identiﬁes the last residue of NS2B, for which electron density was observed in the complex with
BPTI (PDB ID: 3U1J [10]). The positions of selected residues are indicated.
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2.1. Expression plasmids
The DENV-2 NS2B–NS3 protease was produced without a cova-
lent link between NS2B and NS3pro, using a previously described
construct in which NS2B is separated from NS3pro by the natural
protease recognition sequence EVKKQR [7]. The entire construct
consists of the T7 gene 10N-terminal peptide MASMTG followed
by a two-residue cloning artifact (Leu-Glu), 47 residues from
NS2B, the cleavage sequence EVKKQR, 185 residues from NS3pro
and a C-terminal His6-tag. The gene was inserted into the pETMCSI
expression vector [29] and the plasmid was transformed into the
Escherichia coli strain Rosetta::kDE3/pRARE. An additional con-
struct contained the single-cysteine mutation S68C in NS3pro for
subsequent ligation with lanthanide tags [5]. The nucleotide
sequence of BPTI [30] was also subcloned into the pETMCSI T7
expression vector and transformed into the E. coli strain TOP10
(Life Technologies, Carlsbad, CA, USA). The N-terminus was pre-
ceded by a His6-tag followed by the tobacco etch virus (TEV) pro-
tease cleavage sequence ENLYFQG.
2.2. Protein sample preparation
Uniformly and selectively 15N-labelled samples of the protease
weremade by high-cell density in vivo expression [31] and cell-free
synthesis [32–34], respectively, andpuriﬁedas describedpreviously
[7]. BPTI samples selectively labelledwith 15N-labelled Ala, Arg, Lys,
Thr, Leu, Phe and Ile (Cambridge Isotope Laboratories, Andover, MA,
USA; ISOTEC, St. Louis, MO, USA) were prepared by cell-free synthe-
sis at 30 C overnight following a published protocol that includes
His6-tagged disulﬁde bond isomerase C (DsbC) to catalyze correct
disulﬁde bond formation [30]. The reaction volume was 1 mL in a
dialysis tube of Spectra/Por 2 (MWCO: 12–14 kDa) suspended in
10 mL outer buffer. The protein was puriﬁed by diluting the super-
natant of the cell-free reactionwith 2 times buffer A (50 mMHEPES,
pH 7.5, 300 mM NaCl), loading the mixture onto a Ni-NTA agarose
spin column (Qiagen, Hilden, Germany), washingwith buffer A plus
30 mM imidazole and elutingwith buffer A plus 300 mM imidazole.
BPTI was separated from DsbC by a spin column containing SP-
650 M resin (TOSOH, Minato, Japan), using buffer B (50 mM HEPES,
pH 8.0)with 50 mMNaCl for loading, buffer Bwith 100 mMNaCl for
washing and buffer Bwith 1 MNaCl for elution. All puriﬁed proteins
were exchanged into NMR buffer (20 mMMES, pH 6.5, 50 mMNaCl,
10% D2O). Protein concentrations were determined by their UV
absorbance at 280 nm.Samples of the protease–BPTI complex were prepared either
with 15N-labelled protease and unlabelled BPTI or vice versa. Tag-
ging of the S68C mutant of the protease was performed after for-
mation of the 1:1 complex with BPTI by addition to a 3-fold
excess of the C2 tag loaded with either Y3+ or Tb3+ [35,5]. Following
5 h incubation at room temperature, the complex was washed with
NMR buffer using a centrifugal ﬁlter unit (Amicon Ultra with a
MWCO of 3 kDa; Millipore, Billerica, USA).
2.3. NMR spectroscopy
All NMR spectra were recorded of 0.1–0.2 mM solutions of
the protease-BPTI complex in NMR buffer at 25 C, using a
Bruker 800 MHz NMR spectrometer equipped with a TCI
cryoprobe. PCSs were measured in ppm as the amide proton
chemical shifts measured in the presence of a paramagnetic
lanthanide minus the chemical shift observed in the presence
of diamagnetic Y3+.
2.4. Dv-tensor ﬁtting
The PCS of a nuclear spin, DdPCS, is measured in ppm as the dif-
ference in chemical shift between a sample with a paramagnetic
ion (Tb3+ in the present work) and a sample with a diamagnetic
ion. PCSs arise from an anisotropic magnetic susceptibility (Dv)
tensor associated with the unpaired electrons of the paramagnetic
ion. PCSs follow the equation [36]:
DdPCS ¼ 1=ð12pr3Þ½Dvaxð3 cos2 h 1Þ þ 1:5Dvrh sin2 h cos 2/ ð1Þ
where DdPCS is the PCS, r is the distance of the nuclear spin from the
metal ion, Dvax and Dvrh are the axial and rhombic components of
the Dv tensor, and h and / are the polar angles describing the posi-
tion of the nuclear spin with respect to the principal axes of the Dv
tensor. PCSs from lanthanide tags can be measured for nuclear spins
over 40 Å from the metal ion [37].
The PCSs measured for the complex of NS2B–NS3pro with BPTI
were used to determine the position and orientation of the mag-
netic susceptibility anisotropy (Dv) tensors of the paramagnetic
ions relative to the protein structure. The program Numbat [38]
was used to ﬁt the Dv tensors to the crystal structure of the com-
plex with BPTI (PDB ID: 3U1J [10]). As no electron density of NS2Bc
was observed in the structure 3U1J, the coordinates of NS2Bc in the
crystal structure with the peptide inhibitor Bz-nKRR-H (PDB ID:
3U1I [10]) were grafted onto the 3U1J structure for a complete
model of the closed conformation.
Table 1
Dv-tensor parameters of the protease–BPTI complex with the C2-Tb3+ tag attached to
residue 68 of NS3proa.
Dvax Dvrh x y z a b c
Fit 1b 12.3 4.0 16.098 34.428 3.681 146.1 48.9 30.1
(0.1) (0.6) (0.3) (0.3) (0.2) (2.5) (1.2) (4.7)
Fit 2c 12.9 1.9 16.800 33.423 3.582 144.0 50.9 67.7
(0.2) (0.3) (0.1) (0.3) (0.1) (1.5) (0.6) (3.1)
a Dv-tensor parameters determined by the program Numbat using the crystal
structure 3U1J. The axial and rhombic components of the Dv tensors are given in
1032 m3 and the Euler angles in degrees, using the zyz convention and unique
tensor representation [38]. Uncertainties (in brackets) were estimated by randomly
omitting 10% of the PCS data in multiple tensor ﬁts.
b Fit 1 used only PCSs from NS3pro and residues 55⁄–65⁄ of NS2B. The root mean
square deviation (rmsd) between the experimental and back-calculated PCSs was
0.014 ppm for the residues included in the ﬁt.
c Fit 2 used only PCSs from NS3pro, residues 55⁄–65⁄ of NS2B, and PCSs from
those BPTI amides, which are within 30 Å from the paramagnetic metal centre
determined by Fit 1. The rmsd between the experimental and back-calculated PCSs
was 0.029 ppm for the residues included in the ﬁt.
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3.1. The complex of the protease with BPTI is stable
Producing the protease as a single polypeptide chain with a
self-cleavage site between NS2B and NS3pro ensured a precise
1:1 ratio of both components in the ﬁnal protease. Cell-free synthe-
sis of BPTI produced correctly folded, selectively 15N-labelled
protein (Fig. S1), yielding well-resolved 15N-HSQC cross-peaks that
were straightforward to assign to individual residues by compari-
son with resonance assignments of the free protein (Fig. 2B).
In our hands, samples of the protease without covalent link
between NS2B and NS3pro are stable for only a few hours at room
temperature in the absence of inhibitor. Sample degradation
results in additional narrow cross-peaks from NS2B at random coil
chemical shifts which, previously, had erroneously been attributed
to open conformations [39,40,5]. Notably, 15N-HSQC spectra of the
complex with BPTI were free of these additional cross-peaks and
stable for at least a month, indicating that BPTI inhibits the
degradation of the protease (Fig. S2).
3.2. The binding mode of BPTI in solution is the same as in the crystal
Fig. 2 illustrates the PCSs observed for the complex of the S68C
mutant of the protease with BPTI, with the C2-Tb3+ tag ligated to
Cys68. The same construct ligated with diamagnetic C2-Y3+ served
as the diamagnetic reference. PCSs of NS2B–NS3pro were observed
in the sample of 15N-labelled protease with unlabelled BPTI
(Fig. 2A), while PCSs of BPTI were observed in the sample of selec-
tively 15N-labelled BPTI with unlabelled protease (Fig. 2B). Using
the previously established assignment of the protease [5], 21 PCSs
could be resolved for NS3pro and residues 55⁄–65⁄ of NS2Bn, and 8
PCSs for NS2Bc (Table S1). Owing to the better spectral resolution
in the selectively 15N-labelled BPTI sample, PCSs could be assigned
and accurately measured for 23 residues of the BPTI construct.
To verify that BPTI binds to the protease in solution as reported
by the crystal structure 3U1J, we used the PCSs from NS3pro and
NS2Bn to ﬁt an initial Dv tensor to the crystal structure (Fit 1 in
Table 1). The good quality of the ﬁt is illustrated by the close cor-
relation between experimental and back-calculated PCSs (Fig. 3A).
Using the ﬁtted Dv tensor together with the crystal structure coor-
dinates of the DENV-3 protease-BPTI complex (PDB ID: 3U1I [10])
to predict the PCSs of BPTI reproduced the expected trend (Fig. 3C).
This shows that the inhibitor binds in solution as reported by theFig. 2. PCSs observed for the complex of NS2B–NS3 protease with BPTI. (A) Superimposit
C2-Tb3+ (red spectrum) or C2-Y3+ (black spectrum), in complex with unlabelled BPTI. PCSs
isotopic abundance and BPTI is selectively labelled with 15N-Ala, Arg, Lys, Thr, Leu, Phe a
were observable only at the noise level. Asterisks identify unassigned resonances attribcrystal structure (Fig. 3E). This conclusion is unaffected by the
observation that the back-calculated PCSs of BPTI were consis-
tently more positive than the experimental PCSs (Fig. 3C). Discrep-
ancies of this magnitude are common for mobile tags like the C2
tag, as translational motions of the metal ion compromise the
accuracy with which the PCS data can be approximated by a single
effective Dv tensor [41].
3.3. NS2Bc retains the closed conformation in the presence of BPTI
To obtain more accurate predictions for the PCSs of NS2Bc in the
closed conformation, we accepted the correctness of the crystal
structure 3U1I [10] with regard to the position of BPTI and deter-
mined a new Dv tensor using amide PCSs of residues from NS3pro,
NS2Bn and, in addition, BPTI, so long as they were within 30 Å of
the metal ion position determined by Fit 1. The resulting ﬁt (Fit 2
in Table 1) still produced good agreement between back-calculated
and experimental PCSs (Fig. 3B) and accurately predicted the PCSs
also for BPTI residues located further than 30 Å from the metal cen-
tre (Fig. S3B). Most important, however, the PCSs predicted for
NS2Bc in the closed conformation of the crystal structure (3U1I
[10]) very closely matched the experimental data (Fig. 3D). This
indicates that NS2Bc is in the closed conformation as in the crystalion of 15N-HSQC spectra of uniformly 15N-labelled protease S68C, tagged with either
of NS2Bc residues are labelled. (B) Same as (A), except that the protease is at natural
nd Ile. PCSs of BPTI are identiﬁed by lines. Cross-peaks of residues 15 (circle) and 17
uted to the modiﬁed N-terminus and the nearby C-terminus.
Fig. 3. Correlation between experimental and calculated PCSs for the complex of NS2B–NS3pro with BPTI. (A) Back-calculated versus experimental PCSs produced by Fit 1 of
Table 1. Data of NS2B (residues 55⁄–65⁄) and NS3pro are shown as red squares and black circles, respectively. (B) Same as (A), except showing the data from Fit 2. PCSs from
BPTI are shown as blue triangles. (C) PCSs of BPTI predicted by the Dv tensor of Fit 1 versus the amino-acid sequence of BPTI. Experimental and calculated data are shown as
black and white triangles, respectively. (D) PCSs of NS2Bc predicted by the Dv tensor of Fit 2 versus the amino-acid sequence of NS2Bc. Experimental and calculated data are
shown as black and white squares, respectively. (E) Cartoon representation of the structure 3U1J with NS2Bc copied from the structure 3U1I [10]. The N-terminal segment of
NS2B is shown in orange, NS2Bc in light orange, NS3pro in grey and BPTI in cyan. The link between residues 69⁄ and 70⁄ is indicated by dots. The green sphere highlights the
site of the cysteine residue carrying the lanthanide tag (residue 68). (F) PCS isosurfaces (±0.5 ppm) generated by the Dv tensor of Fit 2 (Table 1) plotted on the structure of the
protease–BPTI complex. Blue and red surfaces identify, respectively, positive and negative PCSs. The amides for which PCSs were measured and used in the ﬁt are identiﬁed by
spheres. Light orange balls illustrate amides of NS2Bc for which experimental PCSs were measured. The same data are displayed in two different orientations.
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by NMR in the absence of an inhibitor [7]. Using the PCSs to ﬁt a
Dv tensor to NS2Bn and NS3pro in the open conformation of
Fig. 1A (2FOM [4]) predicted completely wrong PCSs for NS2Bc,
conﬁrming that this conformation cannot be populated to any sig-
niﬁcant extent in the complex with BPTI (Fig. S4).
Our results suggest that the open conformation observed in the
crystal structure of the protease–BPTI complex could be a crystal-
lization artifact. Indeed, inspection of intermolecular contacts in
the crystal lattice show that a symmetry-related molecule occupies
much of the space where the b-hairpin of NS2Bc would be
expected to be in the closed conformation (Fig. S5).
4. Discussion
The present work demonstrates that the C-terminal b-hairpin of
NS2B retains the closed conformation in solution also when BPTI isbound to the dengue virus NS2B–NS3 protease. Previous solution
NMR data showed that the protease assumes the closed conforma-
tion also in the absence of an inhibitor [6,7]. Without exception,
the closed conformation thus is the overwhelmingly predominant
conformation in solution, regardless of the presence or absence of
inhibitors of high or low molecular mass. These results are in stark
contrast to the crystal structure determinations of the NS2B–NS3
protease, which reported NS2Bc exclusively in open conformations
except for a single case in which a small peptide inhibitor was
bound to the protease [4,42,10]. Our results have important impli-
cations for rational drug design: while the crystallizations indicate
that the association between NS2Bc and NS3pro may be weak, the
closed conformation, as observed in the crystal structure with a
small peptide inhibitor [10], is the most faithful representation of
the protease structure to use in drug development efforts.
Notably, the NS2B–NS3 protease is subject to conformational
changes, as indicated by non-uniform peak intensities in the
2210 W.-N. Chen et al. / FEBS Letters 588 (2014) 2206–221115N-HSQC spectra (Fig. 2A). High pH (7.5 versus 6.5) or high concen-
trations of NaCl (300 mM) in the absence of any inhibitor have been
observed to broaden the signals of NS2Bc after Ser71⁄ beyond detec-
tion, which can be attributed to an equilibrium between open and
closed conformations (with residues preceding Ser71⁄ retaining
their location in the closed state) or to conformational changes
within the closed state [7]. The non-uniform peak intensities in
the presence of BPTI indicate that the inhibitor does not eliminate
all conformational exchange processes in the protease. As the PCSs
ofNS2Bc closelymatch the expectations for the closed conformation
and we could not observe signals of an additional conformation, we
estimate that at most 10% of NS2Bc in an open conformation could
have escaped detection.
On a technical note, our data illustrate the power of pseudocon-
tact shifts for the structure analysis of proteins and protein–ligand
complexes in aqueous solution, even if the lanthanide tag is attached
via a fairly ﬂexible linker. An earlier analysis of the C1 tag (which is
the opposite enantiomer of the C2 tag used here) attached to the
NS2B–NS3 protease concluded that themobility of the tag can com-
promise the prediction of accurate PCSs of a ligand, if a single effec-
tive Dv tensor is ﬁtted to all experimental PCS data of the protein
[41]. This effect arises from the fact that, in principle, displacements
of the metal requires the ﬁtting of multipleDv tensors for accurate
PCS back-calculations. Much improved PCS predictions are already
expected, however, if a single effectiveDv tensor is ﬁtted to a subset
of PCSs measured for nuclear spins in the vicinity of the ligand. This
expectation is borne out by the experimental data of the present
work, as the PCSs predicted for NS2Bc matched the experimental
results much better, when PCSs from nuclear spins of BPTI were
included to ﬁt theDv tensorwhile excluding those BPTI amides that
were located far from themetal site. In this way, the approximation
of the PCSdata by a single effectiveDv tensor resulted in a goodﬁt of
PCSs for nuclear spins in the vicinity of NS2Bc (Fig. 3F), producing a
meaningful prediction of PCSs for NS2Bc and comparison with
experimental PCSs.
In conclusion, our results stress the stability of the closed con-
formation of the dengue virus NS2B–NS3 protease, at least for sero-
type 2 which is the serotype with the highest global growth rate
over the last decade [43]. NMR studies of the other serotypes will
be required to assess the effect of sequence differences on the
prevalence of open conformations. Our results also highlight the
way in which PCSs induced by fairly mobile lanthanide tags can
be used to obtain useful structural information in solution for pro-
tein systems that are difﬁcult to analyse in detail by conventional
techniques.
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